Vedecké štúdie

Nezávislý, recenzovaný výskum o metabolizme tyrozínu v moči a jeho spojení s rôznymi zdravotnými stavmi.

Dôležité Tieto publikácie sú poskytnuté len na vedecké účely. CCI REAGENT je orientačný screening pomôcka na tyrozín, nie diagnostický test. Pozitívny výsledok neindikuje rakovinu ani žiadnu špecifickú chorobu a musí byť posúdený zdravotníckym odborníkom.

Vybrané publikácie

Nasledujúce nezávislé štúdie poskytujú vedecký kontext pre screening tyrozínu v moči. Sú to výskumy tretích strán a nepredstavujú tvrdenia o CCI REAGENT.

Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer

PubMed

Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically

ScienceDirect

Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins

Nature

Urinary tyrosine-phosphorylated proteins: a non-invasive marker for diagnosis, prognosis and follow-up for bladder cancer

MirrorsMed

Tyrosine, Phenylalanine, and Tryptophan in Gastroesophageal Malignancy

AACR Journals

Application of metabolomics in the diagnosis of breast cancer

PubMed Central

Evaluation of aromatic amino acids as potential biomarkers in breast cancer by Raman spectroscopy

Nature Scientific Reports

Review and Comparison of Cancer Biomarker Trends in Urine as a Basis for New Diagnostic Pathways

MDPI Cancers

Urinary Metabonomic Study on Colorectal Cancer

ACS Publications

Urinary Metabolites as Biomarkers for Diagnosis of Breast Cancer

Journal of Breast Disease

Metabonomics studies on serum and urine of patients with breast cancer using 1H-NMR spectroscopy

Oncotarget

Raman Spectroscopy Reveals Abnormal Changes in the Urine Composition of Prostate Cancer

Wiley

Detection of tyrosine and monitoring tyrosinase activity using an enzyme cascade-triggered colorimetric reaction